ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MXCN Maxcyte Inc

680.00
0.00 (0.00%)
10 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Maxcyte Inc MXCN 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 680.00 09:00:00
개장가 저가 고가 종가 전일 종가
680.00 680.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202405:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
10/04/202421:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
02/04/202421:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
13/03/202405:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
05/03/202406:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
09/02/202422:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
30/01/202422:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
23/01/202422:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
09/01/202406:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
03/01/202422:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
02/01/202416:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
12/12/202306:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
16/11/202322:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
09/11/202306:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
07/11/202306:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
05/10/202305:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..
06/09/202321:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Executive Vice..
05/09/202321:05GLOBEMaxCyte to Participate in Baird Global Healthcare Conference
10/08/202305:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2023 Financial..
01/08/202321:05GLOBEMaxCyte Signs Strategic Platform License with Prime Medicine..
13/07/202321:05GLOBEMaxCyte to Report Second Quarter 2023 Financial Results on..
10/07/202321:05GLOBEMaxCyte and Vittoria Biotherapeutics Sign Strategic Platform..
06/07/202321:05GLOBEMaxCyte Signs Strategic Platform License with Lyell..
02/06/202305:05GLOBEMaxCyte to Participate in Upcoming Investor Conferences